By Juan-Carlos Rodriguez ( October 12, 2012, 5:47 PM EDT) -- A Questcor Pharmaceuticals Inc. shareholder on Thursday lodged a derivative complaint against the company's top executives, accusing them of lying about the efficacy of their main drug to inflate the price of the company's stock shortly before Aetna Inc. reduced reimbursements for it....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.